The “
Global Biomarkers Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast ” by DecisionDatabases.com evaluates and analyses the biomarkers market worldwide. The report provides estimates in terms of revenue for the forecast period. It also includes the detailed information of the value chain, latest trends, forecasts, innovation, drivers, and restraints.
A biomarker, mainly known as a “biological marker” is a measurable indicator of biological processes, pharmacological processes or pathogenic responses to a curative intervention. The growing healthcare industry and increasing R&D investment towards drug discovery are the major drivers pushing the growth of
biomarkers market. In addition, the rising demand of biomarkers for various disease-diagnostic purposes is also likely to fuel market demand over the study period.
Biomarkers were developed to understand the connection between environmental factors & diseases though now it’s becoming an upcoming trend in the medical industry. Rising application of biomarkers in various tools and technologies including prediction, diagnosis, regression, cause, progression and outcome of various diseases is expected to augment industry growth in the near future. However, low ROI, high cost of biomarker test and unfavorable regulatory and reimbursement policies are the key market restraints, which may hamper the growth of the global biomarkers market over the coming years.
The global biomarkers market is segmented by product into services, consumables and software segment. The market is further segmented by type into validation biomarkers, efficacy biomarkers, and safety biomarkers. Furthermore, efficacy biomarkers segment is divided into pharmacodynamic biomarkers, prognostic biomarkers, predictive biomarkers, and surrogate biomarkers. On the basis of disease indication, the market is segmented into immunological disorders, cancer, neurological disorders, cardiovascular disorders and other diseases. By application biomarkers market is divided into drug discovery and development, disease risk assessment, diagnostics development, personalized medicine and other applications.
Growing demand for biomarkers as modified solutions for cancer treatment and prevention is expected to open new avenues for the industry growth over the coming years. Rising demand for biomarkers test for the diagnosis of prostate cancer is a major breakthrough and it is anticipated to drive market demand over the forecast period. Supportive FDA policies to promote the application of biomarkers in basic, clinical, and potential research will have positive impact on the market growth of the biomarkers in future trials.
Increasing application scope of biomarkers to a wide variety of therapeutic areas including neurological disease, metabolic disorders and immune deregulation is projected to boost market demand for biomarkers in the near future. The predominant field of biomarkers-application lies in oncology, which in turn will further drive the industry growth of biomarkers across the globe.
North America is the leading market and is anticipated to witness a substantial growth over the forecast period owing to growing healthcare industries in the region. Asia Pacific is becoming one of the major market and is anticipated to show outstanding growth over the coming years on account of expansion of biomarkers market and rising R&D expenditure in the region, especially in China and India.
Major industry players for biomarkers include Bio-Rad Laboratories, Qiagen N.V., Singulex, Inc., Signosis, Inc., Meso Scale Diagnostics, LLC, Biosims Technologies, Merck & Co, Inc., ENZO Biochem, Inc., EKF Diagnostics Holdings, Inc., Inc., Perkinelmer, Inc. and Cisbio Bioassays.
Other Related Reports
About-Us:
DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.
Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise and meaningful data at a lightning speed.
For more details:
DecisionDatabases.com
E Mail:
[email protected]
Phone: +91 99 28 237112
Web:
www.decisiondatabases.com/